Bruck Syndrome

Other names
Types
Causes
Symptoms and signs
Diagnostic tests
Non-pharmacological treatments (therapies & others)
Drug treatments
Dietary molecular supplements
Drugs for immunity booster, regenerative, stem cell
Surgeries (procedures and why they’re done)
Preventions
When to see doctors (red-flags)
What to eat” vs “what to avoid
Frequently asked questions (FAQs)

Bruck syndrome is a rare genetic bone and joint disorder. Babies are born with stiff joints (called contractures) and bones that break easily. Doctors describe it as a mix of two things seen together: arthrogryposis (many joints are stiff at birth) and osteogenesis imperfecta (OI) (bones are fragile). The core problem lies in collagen, the main protein that gives bones and connective tissues their strength. In Bruck syndrome, the body cannot cross-link collagen fibers properly, so the bone framework is weak and the joints become tight. The condition is inherited in an autosomal recessive pattern, which means a child gets a faulty copy of a gene from each parent. rarediseases.org+2orpha.net+2

Bruck syndrome is a very rare genetic condition that combines two major problems from birth: (1) fragile bones that break easily (like osteogenesis imperfecta) and (2) joint contractures (stiff joints that cannot move through a full range). Most known cases are due to changes in two genes, FKBP10 or PLOD2. These genes are important for how collagen (the main “rebar” protein in bone and connective tissue) is folded and cross-linked. When collagen is built incorrectly, bones are weak and joints can form tight bands that limit movement. Children can have fractures, curved spine, short stature, and progressive deformities. Care is lifelong and involves a team: orthopedics, physical/occupational therapy, genetics, and rehabilitation medicine. Drug treatments used in osteogenesis imperfecta (like bisphosphonates) are sometimes used off-label in Bruck syndrome to improve bone density; surgery and therapy address deformity and stiffness. PMC+2orpha.net+2

At the molecular level, most people with Bruck syndrome have disease-causing changes in one of two genes. Type 1 is linked to the FKBP10 gene, which encodes a chaperone protein (FKBP65) that helps collagen fold correctly in the endoplasmic reticulum. Type 2 is linked to the PLOD2 gene, which encodes lysyl hydroxylase 2 (LH2)—an enzyme that adds a chemical group (a hydroxyl) to specific lysine residues in collagen telopeptides. This step is essential for pyridinoline cross-links that make collagen strong. When these genes do not work, collagen cross-linking is poor, bones are fragile, and joints may be fixed or tight from birth. PMC+2MDPI+2

Other names

People and resources may call Bruck syndrome by several names. These names all point to the same pattern of bone fragility with congenital contractures:

Osteogenesis imperfecta with congenital joint contractures (describes both key features together). rarediseases.org
Arthrogryposis with bone fragility (plain description used in case reports and databases). rarediseases.org
Bruck syndrome type 1 / type 2 (based on the gene involved, FKBP10 or PLOD2). orpha.net
Sometimes it is labeled a recessive OI variant because of shared features with osteogenesis imperfecta. Frontiers

Types

Type 1 (FKBP10-related)
This type happens when both copies of the FKBP10 gene have harmful variants. FKBP65 is a collagen-folding chaperone. When it is missing or faulty, type I collagen does not fold and assemble correctly. This leads to under-hydroxylated collagen telopeptides and fewer strong cross-links, so bones are weak and joints may be stuck. Some families show Bruck features; others show recessive OI with overlapping signs. PubMed+1

Type 2 (PLOD2-related)
This type happens when both copies of PLOD2 have harmful variants. PLOD2 makes lysyl hydroxylase-2 (LH2), the enzyme that prepares collagen for strong cross-linking. Without LH2, the normal hydroxylysylpyridinoline cross-links are low, so the collagen network is weak. That is why bones fracture easily and joints can be contracted. rarediseases.info.nih.gov+1

Notes on variation
Doctors have reported variants where contractures are mild or even absent, or where the condition is first noticed because of fractures and short stature. This shows that the same gene changes can look a bit different in different people. PMC+1

Causes

Important note: The root cause is genetic—two faulty copies of FKBP10 or PLOD2. The items below explain detailed mechanisms and contexts that “cause” or contribute to the disease features.

Biallelic FKBP10 variants lead to lack or malfunction of FKBP65, a collagen-folding helper; collagen misfolds and assembles poorly. PubMed+1
Biallelic PLOD2 variants reduce LH2 activity; collagen telopeptides are under-hydroxylated and cross-linking is weak. rarediseases.info.nih.gov+1
Defective collagen cross-linking (low hydroxylysylpyridinoline) directly weakens bone matrix. PMC
Abnormal collagen folding adds stress inside bone-forming cells (osteoblasts) and limits normal bone building. MedlinePlus
Reduced collagen fibril strength leaves bones fragile and prone to fractures with minor trauma. rarediseases.org
Stiff fetal joints from abnormal connective tissue can form in the womb, leading to congenital contractures. PMC
Endoplasmic reticulum (ER) stress in osteoblasts from misfolded procollagen can impair bone formation. MedlinePlus
Tendon and ligament weakness due to faulty collagen contributes to joint deformities and pterygia. rarediseases.org
Abnormal bone remodeling signals secondary to weak matrix can worsen osteopenia. (Inference consistent with OI biology.) NCBI
Founder variants in some populations raise risk within families due to shared ancestry. (Rare-disease pattern noted across reports.) PLOS
Consanguinity increases the chance both parents carry the same rare recessive variant. (Common in reported pedigrees.) Nature
Splice-site or frameshift mutations that abolish protein production tend to cause severe disease. (Shown in case series.) PLOS
Missense mutations that reduce enzyme activity of LH2 or stability of FKBP65 also cause disease but may vary in severity. PMC
Compound heterozygosity (two different variants, one on each allele) is a common genetic pattern in rare cases. PLOS
Skeletal growth plate stress on a weak collagen framework contributes to deformities and short stature. (Mechanistic extrapolation from OI.) NCBI
Abnormal cross-link ratio (hydroxylysylpyridinoline to lysylpyridinoline) indicates faulty cross-link maturation that weakens bone. PMC
Perinatal immobilization from contractures may worsen early muscle and joint development. (Clinical inferences from AMC + OI pattern.) rarediseases.org
Progressive spinal curvature (kyphoscoliosis) evolves because weakened bone cannot resist mechanical loads. rarediseases.org
Recurrent fractures trigger deformities and further reduce mobility, creating a cycle that amplifies disability. rarediseases.org
Broader collagen-processing network defects (interacting chaperones/enzymes) may modify severity in some individuals. (Current research direction.) MDPI

Symptoms and signs

Fragile bones with repeated fractures—breaks can happen after minor falls because bone matrix is weak. rarediseases.org
Congenital joint contractures—elbows, knees, and other joints are stiff at birth and hard to extend or flex. rarediseases.org
Pterygia (webbing)—tight bands of skin/soft tissue around joints form because tissue does not stretch normally. rarediseases.org
Short stature—poor bone strength and deformity slow growth over time. rarediseases.org
Spinal curvature (kyphoscoliosis)—the spine bends because vertebrae are weak and unevenly loaded. rarediseases.org
Limb deformities—repeated fractures and abnormal healing change bone shape. rarediseases.org
Reduced fetal movements—in some pregnancies, babies move less because of early joint stiffness. PMC
Muscle weakness and low bulk—limited movement and contractures reduce normal muscle growth. rarediseases.org
Pain after fractures—pain follows breaks and may become frequent with repeated injuries. rarediseases.org
Delayed motor milestones—sitting, standing, and walking can be late due to fragile bones and stiff joints. rarediseases.org
Wide fontanelles or skull shape changes—seen in some OI-like conditions, because cranial bones are thin. NCBI
Blue sclerae (sometimes)—the whites of the eyes may look blue in some individuals, as in some OI forms. NCBI
Hearing issues (occasionally)—as in other OI variants, hearing loss may appear later in life. NCBI
Dental fragility (sometimes)—teeth may chip or wear easily when dentin is affected. NCBI
Breathing problems (severe cases)—chest wall deformity and spine curves can limit lung expansion. rarediseases.org

Diagnostic tests

A) Physical examination

Full joint contracture check
The clinician gently moves each joint to see where it stops. Fixed flexion or extension shows a contracture. This baseline helps track change over time. rarediseases.org
Fracture history and deformity survey
The doctor looks for past fracture signs, limb bowing, and spine curves. This pattern—fragility plus contractures—points toward Bruck syndrome rather than isolated OI or isolated arthrogryposis. rarediseases.org
Growth and anthropometry
Height, arm span, head size, and weight are measured. Short stature and disproportion can reflect repeated fractures and vertebral changes. rarediseases.org
Skin and soft-tissue observation
Pterygia, tight bands, and reduced skin elasticity around joints support the diagnosis and guide therapy needs. rarediseases.org

B) Manual/functional tests

Range-of-motion (ROM) goniometry
A goniometer measures how far each joint moves. Numbers help plan splinting, therapy, and surgery, and allow progress tracking. (Standard orthopedic practice for contractures.) rarediseases.org
Manual muscle testing
Simple bedside strength grading helps separate weakness from pure joint stiffness. This directs physiotherapy goals. (Standard neuromuscular evaluation.) rarediseases.org
Functional mobility scales (e.g., sitting/standing/walking ability)
Clinicians record how the child moves with or without supports. This shows real-world impact and guides assistive devices. (Rehab standards for OI-like disorders.) NCBI
Spinal flexibility assessment
Bending tests help tell flexible curves from fixed kyphoscoliosis, which affects bracing and surgical decisions. rarediseases.org

C) Laboratory & pathological tests

Genetic testing—targeted genes (FKBP10, PLOD2)
A next-generation sequencing panel for bone fragility and arthrogryposis genes can confirm the exact subtype (Type 1 or Type 2). Confirmation helps with counseling and care. orpha.net
Collagen cross-link studies (HP/LP ratio)
Biochemical tests (e.g., urine or tissue) can find low hydroxylysylpyridinoline cross-links or an abnormal HP:LP ratio, matching the cross-linking defect. PMC
Bone turnover markers (ALP, P1NP, CTX)
These blood tests show how active bone formation and resorption are. Values help tailor treatments, like bisphosphonates, and monitor response. (OI-aligned practice.) NCBI
Serum minerals (calcium, phosphate, vitamin D)
These tests rule out other metabolic bone diseases and set a safe base for therapy. (Standard metabolic bone workup.) NCBI
Histology from bone biopsy (selected cases)
A pathologist may see thin trabeculae and abnormal collagen organization that fit OI-like weakness. Biopsy is not routine but can clarify tough cases. NCBI
ER-stress and collagen processing markers in research settings
Specialized labs may study collagen secretion and ER stress in fibroblasts or osteoblasts to support the molecular diagnosis. (Mechanism shown in FKBP10 studies.) MedlinePlus

D) Electrodiagnostic tests

Electromyography (EMG)
EMG checks whether nerves and muscles work normally. In Bruck syndrome, EMG is usually normal, helping exclude neuromuscular causes for stiffness. (Used to refine differential.) rarediseases.org
Nerve conduction studies (NCS)
These tests measure how fast nerves conduct signals. Normal results support a primary skeletal/connective-tissue problem rather than a nerve disorder. rarediseases.org
Somatosensory evoked potentials (selected cases)
If there are spinal deformities, doctors may study spinal cord pathways to guide surgical planning. (General spine-care practice.) rarediseases.org

E) Imaging tests

Plain X-rays of long bones and spine
X-rays show osteopenia (thin bones), fractures (new or healed), bowing, and spine curves. They are the first-line pictures for diagnosis and follow-up. rarediseases.org
DEXA (bone density scan)
DEXA gives a number (Z-score) for bone density. It helps decide on medications and track improvement or decline over time. (Standard in OI-related disorders.) NCBI
Prenatal ultrasound (in at-risk pregnancies)
Ultrasound can suggest the diagnosis before birth when there are fewer fetal movements, limb contractures, or fractures. Genetic testing confirms it. PMC

Non-pharmacological treatments (therapies & others)

Gentle, lifelong physical therapy (PT)
Description: PT starts early and continues through life. Sessions focus on safe handling, positioning, range-of-motion (ROM), strengthening without impact, and guided milestones (rolling, sitting, standing) to protect bones while preventing contractures from getting worse. Therapists teach families transfers, splint care, and fracture precautions. Hydrotherapy can reduce load on bones while allowing movement. Programs are individualized and adapt after fractures or surgeries.
Purpose: Preserve mobility, prevent further joint stiffness, improve function and confidence, and reduce falls.
Mechanism: Low-load movement keeps joints lubricated, maintains muscle strength as a dynamic “brace” for bones, and counters the natural tendency for connective tissues to tighten. PM&R KnowledgeNow+1
Occupational therapy (OT) and adaptive skills training
Description: OT focuses on everyday tasks—dressing, feeding, toileting, bathing, writing, school access—and selects safe tools (long-handled aids, reachers, soft-grip utensils) and wheelchair/desk setups. OT also addresses energy conservation, splint schedules, and caregiver ergonomics.
Purpose: Maximize independence and safe participation at home and school.
Mechanism: Activity-specific practice builds efficient motor patterns; adapted tools reduce peak forces on fragile bones and tight joints. PM&R KnowledgeNow
Hydrotherapy (aquatic therapy)
Description: Warm-water therapy enables gentle resistance and buoyant support for movement with much lower risk of impact. Therapists use floats and belts to practice gait patterns, trunk control, and ROM.
Purpose: Increase ROM and strength, reduce pain and spasm, and improve confidence.
Mechanism: Buoyancy unloads joints and bones; water drag provides uniform, low-risk resistance to build endurance. PM&R KnowledgeNow
Serial casting and splinting for contractures
Description: Short periods of well-padded casts or thermoplastic splints gradually lengthen tight muscles and tendons at elbows, knees, ankles, or wrists. They’re changed frequently and combined with stretching.
Purpose: Improve joint position for function, bracing, and later surgeries; delay or reduce the need for tendon releases.
Mechanism: Prolonged, gentle stretch remodels connective tissue length (creep) and reduces the mechanical disadvantage caused by fixed flexion. PMC
Custom orthoses (AFOs/KAFOs), safe bracing, and positioning
Description: Lightweight braces stabilize joints for standing and walking practice. Night splints maintain stretch. Wheelchair seating systems prevent pressure sores and scoliosis worsening.
Purpose: Support alignment, reduce falls, and protect healing bones.
Mechanism: External support redistributes forces and limits deforming torques across weak bone and stiff joints. PM&R KnowledgeNow
Fracture prevention plan (home & school safety)
Description: Fall-proofing (non-slip floors, ramps), lifting/transfer training for caregivers, safe car seats and strollers, and school IEP/504 plans with emergency fracture procedures.
Purpose: Reduce fracture risk while enabling participation.
Mechanism: Environmental and procedural changes reduce peak loads likely to cause fractures. PM&R KnowledgeNow
Nutritional optimization for bone health
Description: Ensure age-appropriate calcium and vitamin D intake via food first, then supplements if prescribed. Adequate protein supports muscle; magnesium and vitamin K come from whole foods (greens, legumes, nuts). Hydration and fiber help during cast-immobilization periods.
Purpose: Provide substrates for bone mineralization and muscle function.
Mechanism: Vitamin D improves calcium absorption; calcium supplies mineral; protein provides amino acids for collagen; magnesium and vitamin K participate in bone matrix chemistry. Office of Dietary Supplements+3Office of Dietary Supplements+3Office of Dietary Supplements+3
Pain management without heavy impact
Description: Use heat/cold packs, positioning, cushions, and gentle massage around—not on—healed fractures. Consider cognitive strategies (breathing, distraction). Seek medical guidance before any device that vibrates or compresses.
Purpose: Control pain to enable therapy and sleep.
Mechanism: Non-pharmacologic analgesia reduces nociceptive input and muscle guarding, supporting ROM work. PM&R KnowledgeNow
Scoliosis and spine monitoring
Description: Regular exams and imaging to track kyphoscoliosis. Early bracing and PT address trunk endurance; timely referral to spine surgery when progression threatens lung function.
Purpose: Preserve pulmonary capacity and sitting balance.
Mechanism: Early detection and external support reduce asymmetric loading that drives curvature. PMC
Pulmonary hygiene & infection prevention
Description: Teach breathing exercises, cough assist after surgeries, and vaccination schedules. Manage reflux/aspiration risks and optimize seating to expand lungs.
Purpose: Lower respiratory complications—important when chest wall is fragile and spine is curved.
Mechanism: Better ventilation and airway clearance reduce infection risk and preserve exercise tolerance. BioMed Central
Gait training & mobility tech (walkers, wheelchairs)
Description: Progress from supported standing frames to walkers or customized wheelchairs; choose shock-absorbing tires and lap belts.
Purpose: Safe mobility with minimal fracture risk.
Mechanism: Assistive tech shares load and limits sudden forces across brittle long bones. PM&R KnowledgeNow
School accommodations and psychosocial support
Description: Written plans for extra time, elevator access, safe PE alternatives, counseling, and peer education to reduce stigma.
Purpose: Full participation and mental well-being.
Mechanism: Reduces stress and risky situations; supports adherence to therapy. oamjms.eu
Home exercise program (HEP) with micro-progressions
Description: Daily, brief routines (isometrics, gentle bands, ROM) logged in a simple tracker.
Purpose: Maintain gains between clinic visits.
Mechanism: Frequent, low-dose loading preserves strength without high fracture risk. PM&R KnowledgeNow
Heat therapy for soft-tissue relaxation
Description: Warm packs before stretching and splinting sessions.
Purpose: Easier ROM with less pain.
Mechanism: Heat reduces tissue viscosity and increases elasticity, allowing safer stretch at lower force. PM&R KnowledgeNow
Ergonomic caregiver training
Description: Safe body mechanics for lifting, log-rolling, diapering, and bathing to prevent accidental torque.
Purpose: Protect the child and the caregiver.
Mechanism: Proper mechanics minimize peak loads on fragile bones. PM&R KnowledgeNow
Skin care and pressure-injury prevention
Description: Cushioning, frequent position changes, moisture control under casts/braces.
Purpose: Avoid sores that limit therapy.
Mechanism: Reduces sustained pressure and shear on at-risk skin. PM&R KnowledgeNow
Bone health education for the whole family
Description: Teach red-flags, cast care, fall-proofing, medicine timing, and DEXA scheduling.
Purpose: Better adherence and earlier help-seeking.
Mechanism: Knowledge reduces preventable injuries and complications. PM&R KnowledgeNow
Transition planning (adolescence → adult care)
Description: Prepare for adult services, vocational goals, sexual/reproductive counseling, and independent living skills.
Purpose: Smooth, safe independence.
Mechanism: Anticipatory guidance prevents gaps in critical therapies and meds. PM&R KnowledgeNow
Community participation with risk-smart recreation
Description: Swimming, wheelchair sports, and arts replace high-impact activities; use helmets and guards as advised.
Purpose: Fitness and mental health without excess risk.
Mechanism: Low-impact activity maintains capacity and social connection. PM&R KnowledgeNow
Regular, coordinated multidisciplinary reviews
Description: Periodic team visits (PT/OT/orthopedics/spine/pulmonology/genetics).
Purpose: Keep the plan current as the child grows.
Mechanism: Team oversight catches problems early and optimizes timing of surgery or medication. d-nb.info

Drug treatments

Important: No medicine is FDA-approved specifically for Bruck syndrome. Many are used off-label from osteogenesis imperfecta/osteoporosis care to raise bone mineral density and reduce fracture risk. Pediatric use often differs from adult osteoporosis labels; follow specialist guidance. Each item includes ~150 words, class, typical adult dosing from the FDA label (unless noted), timing, purpose, mechanism, and key side effects.

Pamidronate (Aredia®) — IV bisphosphonate
Dose/Timing (label): Cancer/hypercalcemia regimens vary; example single 90 mg IV over ≥2–4 h; not labeled for pediatrics. OI/Bruck use is off-label in cycles (specialist protocols). FDA Access Data+1
Purpose: Increase bone mineral density (BMD), reduce vertebral compression; widely used in OI children; extrapolated in Bruck.
Mechanism: Inhibits osteoclasts (bone-resorbing cells), slowing bone turnover so bone can mineralize better.
Side effects: Flu-like symptoms after infusions, low calcium/phosphate, bone pain; kidney effects—infuse slowly and hydrate.
Evidence note: Controlled pediatric OI trials show improved spine BMD and fewer vertebral compressions (fracture benefits for long bones are mixed). PubMed+1
Zoledronic acid (Reclast®) — IV bisphosphonate
Dose/Timing (label adults): 5 mg IV once yearly for osteoporosis (≥15 min infusion). Pediatric/OI/Bruck use is off-label with specialist dosing. FDA Access Data
Purpose: Potent antiresorptive to improve BMD and reduce fractures in high-turnover bone states.
Mechanism: Nitrogen-containing bisphosphonate binds bone and strongly suppresses osteoclast activity.
Side effects: Acute-phase flu-like reaction, hypocalcemia (ensure calcium/vitamin D), renal effects; rare osteonecrosis of jaw/atypical femur fracture with long-term use. FDA Access Data
Alendronate (Fosamax®) — oral bisphosphonate
Dose/Timing (label adults): 70 mg once weekly (or 10 mg daily) on empty stomach with full glass of water; stay upright ≥30 min. Food markedly reduces absorption. FDA Access Data+1
Purpose: Off-label adjunct for milder phenotypes or maintenance when IV access is difficult.
Mechanism: Inhibits osteoclasts, improving BMD.
Side effects: Esophagitis if dosing instructions ignored, hypocalcemia; rare jaw osteonecrosis with long use.
Risedronate (Actonel®) — oral bisphosphonate
Dose/Timing (label adults): 35 mg once weekly (or 5 mg daily), taken upright with water before food. FDA Access Data+1
Purpose: Similar to alendronate as an off-label option when appropriate.
Mechanism: Osteoclast inhibition → BMD gains.
Side effects: GI irritation, musculoskeletal pain; rare osteonecrosis of jaw/atypical femur fracture.
Ibandronate (Boniva®) — oral/IV bisphosphonate
Dose/Timing (label adults): 150 mg orally monthly or 3 mg IV every 3 months for postmenopausal osteoporosis.
Purpose/Mechanism/Side effects: As above for class; used far less in pediatrics; any use in Bruck is off-label. (Use FDA label for details; clinicians select agent by experience and logistics.)
Teriparatide (Forteo®) — PTH(1-34) anabolic
Dose/Timing (label adults): 20 mcg SC once daily; lifetime duration typically ≤2 years on label. FDA Access Data+1
Purpose: In certain adults (e.g., Bruck adults or OI type I adults), may build bone (off-label in OI/Bruck). Not standard for children.
Mechanism: Intermittent PTH stimulates osteoblasts → new bone formation.
Side effects: Hypercalcemia, dizziness, leg cramps; avoid in patients with risk for osteosarcoma. (Follow label cautions.)
Abaloparatide (Tymlos®) — PTHrP analog, anabolic
Dose/Timing (label adults): 80 mcg SC once daily (postmenopausal osteoporosis).
Purpose/Mechanism: Similar to teriparatide; adult off-label consideration only with specialist oversight.
Side effects: Hypercalciuria, dizziness; duration limits as per label.
Denosumab (Prolia®) — RANKL inhibitor, antiresorptive
Dose/Timing (label adults): 60 mg SC every 6 months with daily calcium (1000 mg) and vitamin D. Discontinuation rebound risk requires transition planning. FDA Access Data+1
Purpose: Option for adults who cannot take bisphosphonates (off-label in OI/Bruck; pediatric caution).
Mechanism: Monoclonal antibody prevents osteoclast formation/function → marked fall in resorption.
Side effects: Hypocalcemia, skin infections, rare jaw osteonecrosis; rebound vertebral fractures if stopped abruptly.
Calcitonin (salmon calcitonin, Miacalcin®) — anti-resorptive analgesic effect in acute vertebral pain
Dose/Timing (label adults): Intranasal 200 IU daily alternating nostrils (or SC/IM).
Purpose: Short-term pain relief after vertebral fractures; modest antiresorptive effect.
Mechanism: Direct osteoclast inhibition; central analgesic pathways for vertebral pain.
Side effects: Rhinitis, nausea. (Use with caution; benefits are limited; confirm current label.)
Calcium (elemental, e.g., calcium carbonate/citrate) — nutrient medication under clinician guidance
Dose/Timing: Age-specific totals; many adults need ~1000–1200 mg/day from diet+supplement; split doses for absorption.
Purpose: Ensure substrate for mineralization, especially during antiresorptive therapy.
Mechanism: Supplies calcium for hydroxyapatite crystals in bone.
Side effects: Constipation, kidney stone risk in excess; interactions with iron/thyroid meds—separate dosing. Office of Dietary Supplements
Vitamin D3 (cholecalciferol) — nutrient medication under clinician guidance
Dose/Timing: Individualized to reach sufficient 25(OH)D levels; common adult maintenance 800–2000 IU/day; pediatric regimens vary.
Purpose: Promote intestinal calcium absorption and bone mineralization.
Mechanism: Increases calcium (and phosphate) absorption; supports osteoblast function.
Side effects: Excess → hypercalcemia; monitor levels, especially with antiresorptives. Office of Dietary Supplements
Magnesium (as prescribed)
Purpose/Mechanism: Cofactor for bone matrix and vitamin D metabolism; correct deficiency to support bone and muscle function.
Cautions: Excess causes diarrhea; deficiency impairs bone health. Office of Dietary Supplements
Vitamin K (dietary or supplement if advised)
Purpose/Mechanism: Gamma-carboxylation of osteocalcin; may support bone quality (evidence mixed).
Caution: Anticoagulant interactions (warfarin). Office of Dietary Supplements
Analgesics (acetaminophen; cautious NSAID use if cleared)
Purpose/Mechanism: Pain control to allow therapy and sleep.
Caution: Avoid NSAIDs around fracture healing or surgery unless your team advises.
Bisphosphonate rotation/maintenance strategies
Description: In long-term users, specialists may adjust drug or interval to balance BMD maintenance vs. oversuppression risks.
Mechanism/Side effects: As per class; requires dental hygiene and periodic drug holidays. FDA Access Data
IV hydration and electrolyte optimization during infusions
Purpose: Reduce acute-phase symptoms and renal stress during IV bisphosphonate therapy.
Mechanism: Maintains renal perfusion; limits hypocalcemia symptoms. FDA Access Data
Antiresorptive precautions (dental checks)
Description: Prevent jaw osteonecrosis—dental exam before potent antiresorptives; avoid high-risk extractions during peak effect if possible.
Mechanism: Reduces local trauma/infection risk during suppressed bone turnover. FDA Access Data
Romosozumab (Evenity®) — sclerostin antibody, anabolic + antiresorptive (adults only)
Use: Strict label indications for postmenopausal osteoporosis; boxed CV warning; any Bruck/OI use would be specialist-level and off-label with careful risk review.

Clinician-directed adjuvants (e.g., phosphate, calcitriol in specific metabolic contexts)
Note: Only when deficiency or specific metabolic bone issues coexist; dosing and monitoring are individualized.

(Where an FDA PDF is not individually linked above, the agent’s class effects and dosing principles follow its FDA label; pediatric/OI/Bruck use remains off-label and tailored by specialists. Key FDA sources: Aredia/pamidronate, Reclast/zoledronic acid, Fosamax/alendronate, Actonel/risedronate, Forteo/teriparatide, Prolia/denosumab.) FDA Access Data+5FDA Access Data+5FDA Access Data+5

Dietary molecular supplements

Vitamin D3 — see above for dosing guidance; supports calcium absorption; deficiency is common and harms bone and muscle. Ensure monitored use to keep levels in the safe range; excess causes hypercalcemia. Office of Dietary Supplements
Calcium — prioritize food first (dairy, fish with bones, fortified foods, greens); supplement only to meet the daily total your clinician sets; split doses for absorption. Office of Dietary Supplements
Magnesium — correct low levels to support bone matrix and neuromuscular function; typical supplements include magnesium citrate or glycinate; high doses cause diarrhea. Office of Dietary Supplements
Vitamin K (K1/K2) — focus on food sources (leafy greens). Supplement only under supervision, especially if on anticoagulants; evidence for fracture reduction is mixed. Office of Dietary Supplements
Protein (dietary; whey/plant only if needed) — aim for age-appropriate intake; protein supports muscle (your “internal brace”) and provides amino acids for collagen; pair with PT for best gains.
Omega-3 fatty acids — anti-inflammatory dietary pattern (fish, nuts) may help comfort and general health; choose food over capsules unless advised.
Vitamin C (as diet priority) — essential for collagen hydroxylation; ensure fruits/vegetables; supplement only if intake is poor.
Zinc (food first) — needed for collagen enzymes and bone turnover; avoid high-dose long-term supplementation due to copper interference.
Copper (food first) — cofactor for lysyl oxidase (cross-links collagen); deficiency is uncommon; supplements only if proven low to avoid toxicity.
Phosphate balance — only if labs indicate a need; overuse harms bone; clinician-directed.

(NIH Office of Dietary Supplements fact sheets support core roles and safe ranges for vitamins D, calcium, magnesium, and vitamin K.) Office of Dietary Supplements+3Office of Dietary Supplements+3Office of Dietary Supplements+3

Drugs for immunity booster, regenerative, stem cell

There are no approved “immunity-booster drugs” for Bruck syndrome. “Regenerative/stem cell” approaches remain investigational. Below are concepts your specialist may discuss in research settings; not standard care.

Mesenchymal stem cell (MSC) therapy (investigational)
Description (~100 words): Experimental MSC infusions or in utero transplantation have been studied in osteogenesis imperfecta to potentially improve collagen production and reduce fracture rate. Results are early and mixed; durability and safety require more trials.
Dose/Function/Mechanism: Dosing varies by protocol; goal is donor cells supporting osteoblast function and paracrine bone repair signals. smw.ch+1
Gene/pathway-targeted therapies (future direction)
Description: Research explores correcting FKBP10/PLOD2 pathways or modulating TGF-β/Wnt signaling.
Function/Mechanism: Aim to improve collagen folding/cross-linking or bone anabolism; currently preclinical/early clinical only. PMC
Teriparatide (see above) as a bone-anabolic in adults
Description: Off-label in selected adults to stimulate bone formation under close supervision.
Dose/Function/Mechanism: 20 mcg SC daily; activates osteoblasts. FDA Access Data
Romosozumab (Evenity®) — adult anabolic/antiresorptive; not for children; cardiovascular cautions.
Function/Mechanism: Sclerostin inhibition increases formation and decreases resorption—off-label discussion only with specialists. PMC
Denosumab (Prolia®) — potent antiresorptive sometimes used when bisphosphonates are unsuitable in adults; requires careful calcium/vitamin D and transition planning to prevent rebound. FDA Access Data
Comprehensive vaccination and infection-prevention plan (not a “booster drug,” but crucial for resilience)
Function/Mechanism: Up-to-date vaccines and pulmonary hygiene reduce illness that could interrupt rehab or worsen scoliosis-related breathing compromise. (Standard public-health guidance via your clinician.)

Surgeries (procedures and why they’re done)

Intramedullary rodding of long bones (e.g., Fassier-Duval rods)
Why: Stabilize bowed or frequently fractured femurs/tibias, enabling safer standing/walking and reducing re-fracture risk.
What happens: Surgeons insert telescoping rods inside the bone to straighten and support it; often with corrective osteotomies. PMC
Tendon release/lengthening for severe contractures
Why: Improve joint ROM for hygiene, brace fitting, transfers, and gait training.
What happens: Tight tendons are surgically lengthened; followed by casting and therapy to maintain gains. PMC
Spinal fusion for progressive kyphoscoliosis
Why: Prevent lung restriction, pain, and seating imbalance when curves progress despite bracing.
What happens: Vertebrae are straightened and fused with rods/screws; recovery involves careful protection and PT. PMC
Guided growth/osteotomies around joints
Why: Correct angular deformities that impair function or brace fit.
What happens: Small plates/screws modulate growth across a physis or bones are cut and realigned. PMC
Foot correction (e.g., clubfoot) with soft-tissue/bony procedures
Why: Achieve plantigrade, braceable feet to improve transfers and mobility.
What happens: Sequential casting (Ponseti principles), then selective releases or osteotomies if needed. PMC

Preventions

Fall-proof the home and school (ramps, rails, non-slip surfaces).
Teach safe transfers and lifting to all caregivers.
Use braces/orthoses as prescribed to control alignment.
Keep up with PT/OT and home exercise to maintain strength and flexibility.
Maintain adequate calcium, vitamin D, and protein through food first; supplement only as advised. Office of Dietary Supplements+1
Schedule regular spine checks to tackle scoliosis early. PMC
Keep vaccinations current; practice pulmonary hygiene. BioMed Central
Plan activities that are low-impact (swimming) and use protective gear.
Dental checkups before and during potent antiresorptives. FDA Access Data
Coordinate care in a multidisciplinary clinic and plan smooth transitions to adult care. d-nb.info

When to see doctors (red-flags)

Any suspected fracture (sudden pain, deformity, swelling, refusal to move a limb).
Worsening tightness or loss of function in a joint despite therapy.
Rapidly progressing spinal curve, new breathing problems, or sleep disturbance. BioMed Central
New dental pain or jaw problems while on antiresorptives. FDA Access Data
Signs of low calcium (muscle cramps, tingling) during bone medicines. FDA Access Data+1

What to eat” vs “what to avoid

Eat more of:

Dairy or fortified alternatives for calcium (milk, yogurt, tofu set with calcium). Bone Health & Osteoporosis Foundation
Oily fish and egg yolks for vitamin D (plus safe sunlight as advised). Office of Dietary Supplements
Leafy greens, beans, and nuts for magnesium and vitamin K. Office of Dietary Supplements+1
Lean proteins (eggs, poultry, legumes) to build muscle.
Colorful fruits/veg for vitamin C and antioxidants.

Limit/avoid:

High-sugar, ultra-processed snacks that displace nutrient-dense foods.
Excess salt (may raise calcium loss in urine).
Excess caffeine or soda; choose water or milk/fortified options.
Crash diets; aim for steady, healthy growth and weight.
High-dose supplements without testing/clinical advice (risk of toxicity or interactions). Office of Dietary Supplements

Frequently asked questions (FAQs)

Is Bruck syndrome the same as osteogenesis imperfecta (OI)?
They overlap but are not identical. Bruck combines OI-like fragile bones plus congenital joint contractures; most cases link to FKBP10/PLOD2 defects in collagen processing. orpha.net+1
Can medicines cure Bruck syndrome?
No cure yet. Some osteoporosis medicines (bisphosphonates, etc.) are used off-label to raise BMD and reduce certain fractures; benefits vary. PMC
Are bisphosphonates safe for children?
They’re widely used in OI pediatrics, but pediatric use is off-label; studies show vertebral benefits with careful protocols. Work with an experienced center. PubMed
What are the biggest risks of IV/strong bone drugs?
Flu-like reactions, low calcium, kidney effects, and very rare jaw bone problems; dosing and dental checks reduce risks. FDA Access Data
Can adults with Bruck use anabolic drugs like teriparatide?
Sometimes, under specialist care; it’s off-label and not for children. FDA Access Data
Will therapy really help contractures?
Yes—early, gentle, consistent ROM, splints, and serial casting can improve or delay worsening; severe cases may still need surgery. PMC
Do braces and walkers make bones “lazy”?
No. They make movement safer and enable training; muscles still work and get stronger with guided use. PM&R KnowledgeNow
Is scoliosis inevitable?
Not always, but it’s common. Early surveillance and bracing/therapy help; surgery is considered if curves progress. PMC
What diet is best?
Food-first for calcium, vitamin D, protein, magnesium, and vitamin K; supplements fill gaps only if your clinician advises. Office of Dietary Supplements+1
Are vitamin D and calcium always needed as pills?
Not always—optimize diet first; supplements are used when intake or levels are low or when you start potent antiresorptives. Office of Dietary Supplements
Do vitamin supplements prevent fractures on their own?
Adequate vitamin D and calcium are necessary for bone health, but supplements alone don’t replace exercise, therapy, and medical/surgical care. Office of Dietary Supplements
Is stem-cell therapy available?
Only in research settings; evidence is still evolving. smw.ch
What about dental care on bisphosphonates or denosumab?
Have a dental exam before treatment and maintain excellent hygiene; report jaw pain or non-healing sores. FDA Access Data
How often are check-ups needed?
Typically every 3–12 months depending on age, growth, treatment cycles, and recent fractures—set by your multidisciplinary team. d-nb.info
What is the long-term outlook?
With modern therapy, surgery, and supports, many people achieve good function and participation, though care is lifelong and individualized. PMC

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: November 03, 2025.

PDF Documents For This Disease Condition

References

SaveSavedRemoved 0